SUPER-PENETRANT ANDROGEN RECEPTOR: OVERCOMING ENZALUTAMIDE SENSITIVITY IN CASTRATION-RESISTANT PROSTATE CANCER
$125,857FY2015Department of the ArmyDOD
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.